Catalyst Pharmaceuticals Inc (CPRX)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | |
| DSO | days | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Based on the provided data, Catalyst Pharmaceuticals Inc did not report any specific values for days of sales outstanding (DSO) for the years ending December 31, 2020 through December 31, 2024. The DSO metric indicates the average number of days it takes for a company to collect revenue after making a sale. As the DSO values are not disclosed, it is challenging to evaluate the efficiency of Catalyst Pharmaceuticals' accounts receivable management and its ability to collect payments from customers in a timely manner. Without this information, it is advisable to look for additional financial data or disclosures to gain deeper insights into Catalyst Pharmaceuticals' performance in managing its accounts receivable.
Peer comparison
Dec 31, 2024